Dr. Mohammad R. Mostafavi , MD
Urology • Springfield, MA
3640 Main St, Suite 103
Springfield, MA 011071145
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on January 23, 2006; this date does not establish years in practice.
-
Published CMS data list 9,617 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 87798 — Detection test by nucleic acid for organism, amplified probe technique: 2,223 service units.
- 87481 — Detection test for candida species (yeast), amplified probe technique: 855 service units.
- 81003 — Automated urinalysis test: 709 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 43 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 1,672 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Tamsulosin Hcl — 447 prescription fills, including refills.
- Finasteride — 204 prescription fills, including refills.
- Gemtesa (Vibegron) — 151 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 27 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 60% of clinicians listed under Urology in Springfield, MA (2024, 15 clinicians with data). Median for this group: 7,597. Middle half: 5,263 to 10,262.
More Medicare Part B services than 90% of clinicians listed under Urology in Massachusetts (2024, 225 clinicians with data). Median for this group: 1,515. Middle half: 592 to 4,241.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 9,330 in 2020 to 9,617 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
3640 Main St
Suite 103
Springfield, MA 011071145
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Urology Group Of Western New England, P.C.. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
Tufts University School Of Medicine
1990
What Public CMS Data Show
Urology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
1,056 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $578,549 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $478,195 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
3,485 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$381,029 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $1,186.93 across 35 records.
By nature of payment
- Food and Beverage: $986.99 across 34 records.
- Travel and Lodging: $199.94 across 1 record.
Reporting-company totals (3 largest of 9)
- Boston Scientific Corporation: $381.03 across 3 records.
- Sumitomo Pharma America, Inc.: $252.95 across 11 records.
- Ferring Pharmaceuticals Inc.: $166.25 across 6 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
36 years (graduated 1990)
CMS Doctors and Clinicians data list 1990 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Mostafavi has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Mostafavi as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Springfield and Massachusetts
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 60% of clinicians listed under Urology in Springfield, MA (2024, 15 clinicians with data). Median for this group: 7,597. Middle half: 5,263 to 10,262.
More Medicare Part B services than 90% of clinicians listed under Urology in Massachusetts (2024, 225 clinicians with data). Median for this group: 1,515. Middle half: 592 to 4,241.
Medicare-allowed amount
A higher Medicare-allowed amount than 90% of clinicians listed under Urology in Springfield, MA (2024, 15 clinicians with data). Median for this group: $403,704. Middle half: $259,155 to $560,615.
A higher Medicare-allowed amount than 95% of clinicians listed under Urology in Massachusetts (2024, 225 clinicians with data). Median for this group: $140,662. Middle half: $71,905 to $260,318.
Paid by Medicare
A higher Medicare payment amount than 90% of clinicians listed under Urology in Springfield, MA (2024, 15 clinicians with data). Median for this group: $321,359. Middle half: $202,458 to $444,593.
A higher Medicare payment amount than 95% of clinicians listed under Urology in Massachusetts (2024, 225 clinicians with data). Median for this group: $101,776. Middle half: $53,181 to $198,312.
Medicare Part D prescriptions
More Part D prescriptions than 75% of clinicians listed under Urology in Springfield, MA (2024, 15 clinicians with data). Median for this group: 1,188. Middle half: 957 to 1,566.
More Part D prescriptions than 70% of clinicians listed under Urology in Massachusetts (2024, 248 clinicians with data). Median for this group: 884. Middle half: 317 to 1,783.
Part D drug cost
A higher Part D drug cost than 90% of clinicians listed under Urology in Springfield, MA (2024, 15 clinicians with data). Median for this group: $112,366. Middle half: $74,491 to $240,117.
A higher Part D drug cost than 90% of clinicians listed under Urology in Massachusetts (2024, 248 clinicians with data). Median for this group: $77,647. Middle half: $20,229 to $203,477.
21 active clinicians are listed under Urology with a practice address in Springfield, MA (377 in Massachusetts).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Springfield
42.9% of these 21 clinicians have the CMS telehealth indicator.
66.7% of these 21 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services varied from year to year: 9,330 in 2020 and 9,617 in 2024.
- 2020: 9,330
- 2021: 9,992
- 2022: 8,538
- 2023: 7,692
- 2024: 9,617
-
Medicare-allowed amount
Medicare-allowed amount increased 10% from $526,974 in 2020 to $578,549 in 2024.
- 2020: $526,974
- 2021: $607,139
- 2022: $525,603
- 2023: $500,983
- 2024: $578,549
-
Paid by Medicare
Paid by Medicare stayed about the same: $439,579 in 2020 and $478,195 in 2024.
- 2020: $439,579
- 2021: $509,528
- 2022: $434,656
- 2023: $403,834
- 2024: $478,195
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 13% from 1,930 in 2020 to 1,672 in 2024.
- 2020: 1,930
- 2021: 1,693
- 2022: 1,843
- 2023: 1,661
- 2024: 1,672
-
30-day fills
30-day fills stayed about the same: 3,831 in 2020 and 3,485 in 2024.
- 2020: 3,831
- 2021: 3,282
- 2022: 3,616
- 2023: 3,361
- 2024: 3,485
-
Part D drug cost
Part D drug cost increased 53% from $249,632 in 2020 to $381,029 in 2024.
- 2020: $249,632
- 2021: $185,327
- 2022: $246,830
- 2023: $253,821
- 2024: $381,029
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $244.39 in 2021 to $1,186.93 in 2025.
- 2021: $244.39
- 2022: $318.97
- 2023: $925.68
- 2024: $1,356.97
- 2025: $1,186.93
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 35 records totaling $1,186.93.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Boston Scientific Corporation |
Travel and Lodging
In-kind items and services
|
Lumenis Pulse 120H | General | $199.94 |
| Boston Scientific Corporation |
Food and Beverage
In-kind items and services
|
Lumenis Pulse 120H | General | $105.07 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $93.75 |
| Boston Scientific Corporation |
Food and Beverage
In-kind items and services
|
Lumenis Pulse 120H | General | $76.02 |
| Ferring Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
ADSTILADRIN | General | $71.19 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $29.96 |
| Antares Pharma, Inc. |
Food and Beverage
In-kind items and services
|
XYOSTED | General | $29.89 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $29.80 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $29.26 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $29.18 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $28.47 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $26.80 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $26.59 |
| COLOPLAST CORP |
Food and Beverage
In-kind items and services
|
Luja Coude | General | $26.43 |
| UROGEN PHARMA, INC. |
Food and Beverage
In-kind items and services
|
JELMYTO | General | $26.31 |
| Endo USA, Inc. |
Food and Beverage
In-kind items and services
|
AVEED | General | $26.11 |
| COLOPLAST CORP |
Food and Beverage
In-kind items and services
|
Luja Coude | General | $24.01 |
| COLOPLAST CORP |
Food and Beverage
In-kind items and services
|
Luja Coude | General | $22.49 |
| UROGEN PHARMA, INC. |
Food and Beverage
In-kind items and services
|
— | General | $20.63 |
| Ferring Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
ADSTILADRIN | General | $20.29 |
| Ferring Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
ADSTILADRIN | General | $19.60 |
| Ferring Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
ADSTILADRIN | General | $19.35 |
| Antares Pharma, Inc. |
Food and Beverage
In-kind items and services
|
XYOSTED | General | $19.34 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $18.94 |
| Antares Pharma, Inc. |
Food and Beverage
In-kind items and services
|
XYOSTED | General | $18.70 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
87798
Detection test by nucleic acid for organism, amplified probe technique
|
2,223 | 142 | $60.00 | $34.19 |
|
87481
Detection test for candida species (yeast), amplified probe technique
|
855 | 142 | $74.65 | $34.07 |
|
81003
Automated urinalysis test
|
709 | 543 | $15.00 | $2.18 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
681 | 487 | $450.00 | $136.57 |
|
51798
Ultrasound measurement of bladder capacity after voiding
|
644 | 488 | $100.00 | $12.34 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
596 | 499 | $250.00 | $95.58 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
590 | 481 | $32.00 | $17.38 |
|
87801
Detection test by nucleic acid for multiple organisms, amplified probe(s) technique
|
513 | 142 | $350.00 | $68.43 |
|
81001
Manual urinalysis test with examination using microscope, automated
|
431 | 325 | $15.00 | $3.10 |
|
88112
Cell examination of specimen, selective cellular enhancement technique
|
338 | 130 | $200.00 | $71.10 |
|
87500
Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique
|
171 | 142 | $75.00 | $34.19 |
|
87640
Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique
|
171 | 142 | $75.00 | $34.19 |
|
87653
Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique
|
171 | 142 | $70.00 | $34.19 |
|
87651
Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique
|
170 | 141 | $70.00 | $34.19 |
|
88120
Cell examination of urine, manual
|
114 | 75 | $1600.00 | $628.96 |
|
76770
Complete ultrasound scan behind abdominal cavity
|
108 | 103 | $300.00 | $81.34 |
|
99443
Telephone medical discussion with physician, 21-30 minutes
|
108 | 96 | $150.00 | $135.24 |
|
J9217
Leuprolide acetate (for depot suspension), 7.5 mg
|
108 | 15 | $750.00 | $178.45 |
|
36415
Insertion of needle into vein for collection of blood sample
|
95 | 79 | $25.00 | $8.47 |
|
52000
Diagnostic exam of bladder and urethra using an endoscope
|
80 | 59 | $750.00 | $256.50 |
|
87086
Bacterial colony count, urine
|
77 | 72 | $25.00 | $7.74 |
|
51741
Electronic assessment of bladder emptying
|
72 | 68 | $188.75 | $13.36 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
57 | 57 | $427.19 | $178.30 |
|
74420
Imaging of urinary tract following injection of a contrast agent
|
42 | 34 | $60.00 | $25.62 |
|
76872
Ultrasound scan of pelvic region through rectum
|
42 | 41 | $650.00 | $149.04 |
(top 25 shown)
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Tamsulosin Hcl | Tamsulosin Hcl | 447 | 33,894 | $9,399.35 | 188 |
| Finasteride | Finasteride | 204 | 17,791 | $3,587.68 | 88 |
| Gemtesa | Vibegron | 151 | 10,074 | $160,108.38 | 62 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 107 | 8,590 | $2,799.26 | 46 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 84 | 5,534 | $2,952.86 | 32 |
| Myrbetriq | Mirabegron | 83 | 3,869 | $57,009.34 | 25 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 66 | 181 | $190.72 | 59 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 66 | 1,592 | $331.80 | 51 |
| Amoxicillin | Amoxicillin | 57 | 763 | $149.33 | 52 |
| Naltrexone Hcl | Naltrexone Hcl | 37 | 1,050 | $1,487.92 | — |
| Fluconazole | Fluconazole | 33 | 749 | $428.16 | 19 |
| Orgovyx | Relugolix | 32 | 960 | $85,038.64 | — |
| Nystatin | Nystatin | 31 | 1,124 | $1,640.97 | 14 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 30 | 218 | $173.89 | 27 |
| Tramadol Hcl | Tramadol Hcl | 29 | 755 | $228.64 | — |
| Methenamine Hippurate | Methenamine Hippurate | 27 | 1,642 | $3,025.27 | 12 |
| Elmiron | Pentosan Polysulfate Sodium | 26 | 990 | $40,764.22 | — |
| Tadalafil | Tadalafil | 25 | 1,632 | $3,669.28 | — |
| Fesoterodine Fumarate Er | Fesoterodine Fumarate | 24 | 774 | $2,103.92 | — |
| Estradiol | Estradiol | 17 | 1,064 | $1,212.60 | 11 |
| Desmopressin Acetate | Desmopressin Acetate | 17 | 690 | $511.89 | — |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 16 | 861 | $955.15 | — |
| Cephalexin | Cephalexin | 14 | 342 | $68.12 | 14 |
| Solifenacin Succinate | Solifenacin Succinate | 14 | 1,080 | $1,214.02 | — |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 12 | 1,080 | $889.23 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 208800000X
A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - UROLOGY
I20081008000012
MA
1052382462
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Urology Group Of Western New England, P.c.
3640 Main St, Springfield, MA 011071139
Phone: 4137855321
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Physician Assistant - Medical
Physician Assistant
Urology
Doctor of Medicine (M.D.)
Urology
Doctor of Medicine (M.D.)
Physician Assistant - Medical
Physician Assistant
Urology
Doctor of Medicine (M.D.)
Urology
Doctor of Medicine (M.D.)
Career & Practice History
NPI enumerated January 23, 2006.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other Urology Specialists in Springfield
- Dr. Andrew Kim, MD
- Dr. William Swanson, MD
- Dr. William Tran, MD
- Dr. Robert White, MD
- Dr. Augustyna Gogoj, MD
- Dr. Susan Glover, MD
Mailing Address
3640 Main St, Suite 103
Springfield, MA 011071145
Phone: 4137855321